Skip to main content
SpringerLink
Log in

Stroke Risk Factors

  • Chapter
Book cover Prevention of Stroke

Abstract

The ideal treatment for stroke, is of course, prevention. This book is dedicated to that premise. To prevent stroke one must be able to identify that portion of the population that is at high risk and to identify factors that contribute to this risk. The remarkable decline in stroke mortality must be related to either a decreased risk for stroke or better treatment. The data suggest that both may be true to some degree. Nevertheless, although better treatment of stroke may have something to do with this decline, the evidence is compelling that recognition, treatment, and altering risk factors to prevent stroke are major reasons. If the purposes of this book are to be accomplished, it is imperative to identify potential risk factors, establish the relative degree of risk, and to remove or treat them appropriately.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mortality trends-United States, 1986–1988. MMWR. 1989;38:117–118.

    Google Scholar 

  2. American Heart Association. Stroke Facts. 1989: p1.

    Google Scholar 

  3. Adelman SM. The National Survey of Stroke: economic impact. Stroke. 1981;12(suppl I):169–178.

    Google Scholar 

  4. Wolf PA, Kannel WB, Verier J. Current status of risk factors for stroke. In: Barnett HJM, ed. Neurologic Clinics, vol 1. no 1. Philadelphia: W.B. Saunders Company; 1983: pp 317–343.

    Google Scholar 

  5. Garraway WM, Whisnant JP, Furlan AJ, et al. The declining incidence of stroke. TV Engl J Med. 1979; 300:449–452.

    Article  CAS  Google Scholar 

  6. Dyken ML, Wolf PA, Barnett HJM, et al. Risk factors in stroke: a statement for physicians by the subcommittee on risk factors and stroke of the stroke council. Stroke. 1984;15:1105–1111.

    Article  Google Scholar 

  7. Kannel WB, Wolf PA, McGee DL, et al. Systolic blood pressure, arterial rigidity, and risk of stroke; the Framingham study. JAMA. 1981 ;245:1225–1229.

    Article  PubMed  CAS  Google Scholar 

  8. Wolf PA. Hypertension as a risk factor for stroke. In: Whisnant JP, Sandok B, eds. Cerebral Vascular Diseases. New York, NY: Grune & Stratton; 1975: p 105.

    Google Scholar 

  9. Kannel WB, Wolf PA, Verier J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke: the Framingham study. JAMA. 1970;214:301–310.

    Article  PubMed  CAS  Google Scholar 

  10. Rutan GH, Kuller LH, Neaton JD, et al. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988;77:504–514.

    Article  PubMed  CAS  Google Scholar 

  11. Shimizu Y, Kato H, Lin CH, et al. Relationship between longitudinal changes in blood pressure and stroke incidence. Stroke. 1984;15:839–846.

    Article  PubMed  CAS  Google Scholar 

  12. Brott T, Thalinger K, Hertzberg F. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986;17:1078–1083.

    Article  PubMed  CAS  Google Scholar 

  13. Sacco RL, Wolf PA, Bharucha NE, et al. Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham study. Neurology. 1984;34:847–854.

    Article  PubMed  CAS  Google Scholar 

  14. Sacco RL, Wolf PA, Kannel WB, et al. Survival and recurrence following stroke: the Framingham study. Stroke. 1982;13:290–295.

    Article  PubMed  CAS  Google Scholar 

  15. Kannel WB, Thorn TJ. Implications of the recent decline in cardiovascular mortality. Cardiovasc Med. 1979;4:983–997.

    Google Scholar 

  16. Carter AB. Hypotensive therapy in stroke survivors. Lancet. 1970; 1:185.

    Google Scholar 

  17. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the hypertension detection and follow-up program: III. Reduction in stroke incidence among persons with high blood pressure. JAMA. 1982;247:633–638.

    Article  Google Scholar 

  18. Taguchi J, Freis ED. Partial reduction of blood pressure and prevention of complications in hypertension. N Engl J Med. 1978;291:329–331.

    Article  Google Scholar 

  19. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: I. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028–1034.

    Article  Google Scholar 

  20. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA. 1970;213:1143–1152.

    Article  Google Scholar 

  21. Ueda K, Omae T, Hasuo Y, et al. Prevalence and long-term prognosis of mild hypertensives and hypertensives in a Japanese community, Hisayama. J Hypertens. 1988;6:981–989.

    Article  PubMed  CAS  Google Scholar 

  22. Cox JP, O’Brien ET, O’Malley K. Treatment of elderly hypertensives: results and implications of recent trials. J Cardiovasc Pharmacol. 1987; 10 (Suppl 2):S65–70.

    Google Scholar 

  23. Samuelsson OG, Wilhelmsen LW, Svardsudd KF, et al. Mortality and morbidity in relation to systolic blood pressure in two populations with different management of hypertension: the study of men born in 1913 and the multifactorial primary prevention trial. J Hypertens. 1987;5:57–66.

    Article  PubMed  CAS  Google Scholar 

  24. Davidson RA, Caranason GJ. Should the elderly hypertensive be treated? Evidence from clinical trials. Arch Intern Med. 1987;147:1932–1937.

    Article  Google Scholar 

  25. MacMahon S, Cutler JA, Stamler J. Antihypertensive drug treatment. Potential, expected and observed effects on stroke and on coronary heart disease. Hypertension. 1989;13:145–150.

    Article  Google Scholar 

  26. Peart S. Results of MRC (UK) trial of drug therapy for mild hypertension. Clin Invest Med. 1987; 10: 616–620.

    PubMed  CAS  Google Scholar 

  27. Doyle AE. The Australian therapeutic trial in mild hypertension. Nephron. 1987;47(Suppl 1): 115 – 119.

    Article  PubMed  Google Scholar 

  28. Tuomilehto J, Piha T, Nissinen A, et al. Trends in stroke mortality and in antihypertensive treatment in Finland from 1972 to 1984 with special reference to North Karelia. J Hum Hypertens. 1987; 1: 201–208.

    PubMed  CAS  Google Scholar 

  29. Fieschi C, Carolei A, Salvetti M, et al. Systemic hypertension as a treatable risk factor for cerebrovascular disease. Am J Cardiol. 1989;63:19C-21C.

    Article  Google Scholar 

  30. Toole JF, Janeway R, Choi K, et al. Transient ischemic attacks due to atherosclerosis: a prospective study of 160 patients. Arch Neurol. 1975;32: 5–12.

    Article  PubMed  CAS  Google Scholar 

  31. Knutsen R, Knutsen SF, Curb JD, et al. Predictive value of resting electrocardiograms for 12-year incidence of stroke in the Honolulu Heart Program. Stroke. 1988;19:555–559.

    Article  PubMed  CAS  Google Scholar 

  32. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982; 306:1018–1022.

    Article  PubMed  CAS  Google Scholar 

  33. Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke, the Framingham study. Neurology. 1978;28:973–977.

    Article  PubMed  CAS  Google Scholar 

  34. Davis PH, Dambrosia JM, Schoenberg BS, et al. Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota. Ann Neurol. 1987; 22:319–327.

    Article  PubMed  CAS  Google Scholar 

  35. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med. 1987;317:669–674.

    Article  PubMed  CAS  Google Scholar 

  36. Petersen P, Godtfredsen J. Risk factors for stroke in chronic atrial fibrillation. Eur Heart J. 1988;9: 291–294.

    PubMed  CAS  Google Scholar 

  37. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke. 1988;19:15–18.

    Article  PubMed  CAS  Google Scholar 

  38. Asinger RW, Dyken ML, Fisher M, et al. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol. 1989; 46:727–743.

    Article  Google Scholar 

  39. Dyken ML, Conneally M, Haerer AF, et al. Cooperative study of hospital frequency and character of transient ischemic attacks: I. Background, organization, and clinical surgery. JAMA. 1977;237:882–886.

    Article  PubMed  CAS  Google Scholar 

  40. Levy DE. How transient are transient ischemic attacks? Neurology. 1988;38:674–677.

    Article  PubMed  CAS  Google Scholar 

  41. Kinkel PR, Kinkel WR, Jacobs L. Nuclear magnetic resonance imaging in patients with stroke. Semin Neurol. 1986;6:43–52.

    Article  PubMed  CAS  Google Scholar 

  42. Salgado ED, Weinstein M, Furlan AJ, et al. Proton magnetic resonance imaging in ischemic cerebrovascular disease. Ann Neurol. 1986;20: 502–507.

    Article  PubMed  CAS  Google Scholar 

  43. Schoenberg BS, Schoenberg DG, Pritchard DA, et al. Differential risk factors for complete stroke and transient ischemic attacks (TIA): study of vascular diseases (hypertension, cardiac disease, peripheral vascular disease) and diabetes mellitus. In: Duvoi-sin RC, ed. Transactions of the American Neurological Association, vol 105. New York, NY: Springer Publishing Company; 1980: p 165.

    Google Scholar 

  44. Weinfeld FD, ed. The National Survey of Stroke. National Institute of Neurological and Communicative Disorders and Stroke. Stroke. 1981; 12 (suppl): 1–1.

    Google Scholar 

  45. Mohr JP, Caplan LR, Melski JW, et al. The Harvard cooperative stroke registry. Neurology. 1978; 28:754–762.

    Article  PubMed  CAS  Google Scholar 

  46. Whisnant JP. The role of the neurologist in the decline of stroke. Ann Neurol. 1983; 14:1–7.

    Article  PubMed  CAS  Google Scholar 

  47. Whisnant JP. Epidemilogy of stroke: emphasis on transient cerebral ischemia attacks and hypertension. Stroke. 1974;5:68–70.

    Article  PubMed  CAS  Google Scholar 

  48. Bousser MG, Eschwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke. 1983;14:5–14.

    Article  PubMed  CAS  Google Scholar 

  49. Canadian Cooperative Stroke Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53–59.

    Article  Google Scholar 

  50. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977;8:301–316.

    Article  PubMed  CAS  Google Scholar 

  51. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Part II: Surgical group. Stroke. 1978;9:309–318.

    Article  PubMed  CAS  Google Scholar 

  52. Sorenson PS, Pedersen H, Marquardsen J, et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke. 1983; 14: 15–22.

    Article  Google Scholar 

  53. Swedish Cooperative Study. High-dose acetylsalicylic acid after cerebral infarction. Stroke. 1987; 18:325–334.

    Article  Google Scholar 

  54. The ESPS Group. The European stroke prevention study (ESPS): principal end-points. Lancet. 1987; 2:1351–1354.

    Google Scholar 

  55. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J (Clin Res). 1988;296:316–320.

    Article  Google Scholar 

  56. Ruether R, Dorndorf W. Aspirin in patients with cerebral ischemia and normal angiograms or nonsurgical lesions: the results of a double-blind trial. In: Breddin K, Dorndorf W, Lowe D, et al., eds. Acetylsalicylic Acid in Cerebral Ischemia and Coronary Heart Disease. Stuttgart: Schattauer; 1978: pp 97–106.

    Google Scholar 

  57. Dyken ML. Anticoagulant and platelet-antiaggre-gating therapy in stroke and threatened stroke. In: Barnett HJM, ed. Neurologic Clinics, vol 1. no 1. Philadelphia, PA: W.B. Saunders Company; 1983: pp 223–242.

    Google Scholar 

  58. Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med. 1989;1321:501–507.

    Article  Google Scholar 

  59. Gent M, Blakely JA, Easton JD, et al., The CATS Group. The Canadian American Ticlopidine study (CATS) in thromboembolic stroke. Lancet. 1989; 1:1215–1220.

    Article  PubMed  CAS  Google Scholar 

  60. Dyken ML. Precipitating factors, prognosis, and demography of cerebrovascular disease in an Indiana Community: a review of all patients hospitalized from 1963–1965 with neurologic examination of survivors. Stroke. 1970;1:261–269.

    Article  PubMed  CAS  Google Scholar 

  61. Paffenbarger RS Jr, Williams JL. Chronic disease in former college students: V. Early precursors of fatal stroke. Am J Public Health. 1967;57:1290–1299.

    Article  CAS  Google Scholar 

  62. Wolf PA, DAgostino RB, Kännel WB, et al. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988;259:1025–1029.

    Article  PubMed  CAS  Google Scholar 

  63. Colditz GA, Bonita R, Stampfer MJ, et al. Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med. 1988;318:937–941.

    Article  PubMed  CAS  Google Scholar 

  64. Menotti A, Mariotti S, Seccareccia S, et al. The 25 year estimated probability of death from some specific causes as a function of twelve risk factors in middle aged men. Eur J Epidemiol. 1988;4: 60–67.

    Article  PubMed  CAS  Google Scholar 

  65. Boysen G, Nyboe J, Appleyard M, et al. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19:1345–1353.

    Article  PubMed  CAS  Google Scholar 

  66. Abbott RD, Yin Y, Reed DM, et al. Risk of stroke in male cigarette smokers. TV Engl J Med. 1986; 315:717–720.

    Article  CAS  Google Scholar 

  67. Shinton R, Beevers G. Meta-analysis of relation between ciagarette smoking and stroke. Br Med J. 1989;298:789–794.

    Article  CAS  Google Scholar 

  68. Kagan A, Harris BR, Winkelstein W Jr, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis. 1974; 27:345–364.

    Article  PubMed  CAS  Google Scholar 

  69. Kagan A, Popper JS, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence in stroke. In: Scheinberg P, ed. Cerebrovascular Diseases. New York, NY: Raven Press; 1976: p 267.

    Google Scholar 

  70. Klatsky AL, Armstrong MA, Friedman GD. Alcohol use and subsequent cerebrovascular disease hospitalizations. Stroke. 1989;20:741–746.

    Article  PubMed  CAS  Google Scholar 

  71. Donahue RF, Abbott RD, Reed DM, et al. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA. 1986;255:2311–2314.

    Article  PubMed  CAS  Google Scholar 

  72. Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267–273.

    Article  PubMed  CAS  Google Scholar 

  73. Hillbom M, Kaste M. Alcohol intoxication: a risk factor for primary subarachnoid hemorrhage. Neurology. 1982;32:706–711.

    Article  PubMed  CAS  Google Scholar 

  74. Lee K. Alcoholism and cerebrovascular thrombosis in the young. Acta Neurol Scand. 1979; 59:270.

    Article  PubMed  CAS  Google Scholar 

  75. Gill JS, Shipley MJ, Hornby RH, et al. A community case-control study of alcohol consumption in stroke. Int J Epidemio. 1988;17:542–547.

    Article  CAS  Google Scholar 

  76. Gorelick PB, Rodin MB, Langenberg P, et al. Is acute alcohol ingestion a risk factor for ischemic stroke? Results of a controlled study in middle-aged and elderly stroke patients at three urban medical centers. Stroke. 1987;18:359–364.

    Article  PubMed  CAS  Google Scholar 

  77. Dintenfass L. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers. Med J Aust. 1975;1:617–620.

    PubMed  CAS  Google Scholar 

  78. Ettinger PO, Wu CF, De La Cruz C Jr, et al. Arrhythmias and the “Holiday Heart”: Alcohol-associated cardiac rhythm disorders. Am Heart J. 1978;95:555–562.

    Article  PubMed  CAS  Google Scholar 

  79. Brust JCM. Stroke and substance abuse. In: Barnett HJM, Mohr JP, Stein BM, et al., eds. Stroke Pathophysiology, Diagnosis and Management, vol 2. New York, NY: Churchill Livingstone; 1986: pp 903–917.

    Google Scholar 

  80. Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch Neurol. 1989; 46:989–993.

    Article  PubMed  CAS  Google Scholar 

  81. Dyer AR, Stamler J, Paul O, et al. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. J Chronic Dis. 1981;34:249–260.

    Article  PubMed  CAS  Google Scholar 

  82. Farid NR, Anderson J. Cerebrovascular disease and hyperlipoproteinemia. Lancet. 1972;1:1398–1399.

    Article  PubMed  CAS  Google Scholar 

  83. Kannel WB. Epidemiology of cerebrovascular disease. In: Russell RWR, ed. Cerebral Arterial Disease. Edinburgh: Churchill Livingstone; 1976: pp 1–23.

    Google Scholar 

  84. Mathew NT, Davis D, Meyer JS, et al. Hyperlipoproteinemia in occlusive cerebrovascular disease. JAMA. 1975;232:262–266.

    Article  PubMed  CAS  Google Scholar 

  85. Kaste M, Koivisto P. Risk of brain infarction in familial hypercholesterolemia. Stroke. 1988; 19: 1097–1100.

    Article  PubMed  CAS  Google Scholar 

  86. Lapidus L, Bengtsson C, Lindquist O, et al. 1988 Triglycerides—main lipid risk factor for cardiovascular disease in women? Acta Med Scan. 1985; 217:481–489.

    Google Scholar 

  87. Kagan A. Popper JS, Rhoads GG, et al. Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke. 1985;16:390–396.

    Article  PubMed  CAS  Google Scholar 

  88. Khaw KT, Barrett-Connor E. Dietary potassium and stroke-associated mortality—a 12 years prospective population study. N Engl J Med. 1987;316: 235–240.

    Article  PubMed  CAS  Google Scholar 

  89. Collaborative Group for the Study of Stroke in Young Women. Oral contraception and increased risk of cerebral ischemia or thrombosis. N Engl J Med. 1973;288:871–878.

    Article  Google Scholar 

  90. Handin RI. Thromboembolic complications of pregnancy and oral contraceptives. Prog Cardiovasc Dis. 1974;16:395–405.

    Article  PubMed  CAS  Google Scholar 

  91. Layde PM, Beral V, Kay CR. Further analyses of mortality in oral contraceptive users. (Royal College of General Practitioners’ Oral Contraception Study). Lancet. 1981;1:541.

    Google Scholar 

  92. Petitti DB, Wingerd J, Pellegrin F, et al. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other factors. JAMA. 1979;242:1150–1154.

    Article  PubMed  CAS  Google Scholar 

  93. Comer TP, Tuerck DG, Bilas RA, et al. Comparison of strokes in women of childbearing age in Rochester, Minnesota and Bakersfield, California. Angiology. 1975;26:351–355.

    Article  PubMed  CAS  Google Scholar 

  94. Schoenberg BS, Whisnant JP, Taylor WF, et al. Strokes in women of childbearing age: a population study. Neurology. 1970;20:181–189.

    Article  PubMed  CAS  Google Scholar 

  95. Shearman RP. Oral contraceptives: where are the excess deaths? Med J Aust. 1981; 1:698.

    PubMed  CAS  Google Scholar 

  96. Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases. N Engl J Med. 1988;319:1313–1317.

    Article  PubMed  CAS  Google Scholar 

  97. Wiseman RA, MacRae KD. Oral contraceptives and the decline in mortality from circulatory disease. Fertil Steril. 1981;35:277–283.

    PubMed  CAS  Google Scholar 

  98. Lidegaard O. Cerebrovascular deaths before and after the appearance of oral contraceptives. Acta Neurol Scand. 1988;75:427–433.

    Article  Google Scholar 

  99. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50. N Engl J Med. 1985;313:1038–1043.

    Article  PubMed  CAS  Google Scholar 

  100. Paganini-Hill A, Ross RI, Henderson BE. Postmenopausal estrogen treatment and stroke: a prospective study. Br Med J (Clin Res). 1988;297:519–522.

    Article  CAS  Google Scholar 

  101. Stampfer MJ, Willett WC, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 1985;313:1044–1049.

    Article  PubMed  CAS  Google Scholar 

  102. Johnson KG, Yano K, Kato H. Cerebral vascular disease in Hiroshima, Japan. Jpn J Chronic Dis. 1967;20:545.

    Article  CAS  Google Scholar 

  103. Katsuki S, Omae T, Hirota Y Epidemiological and clinicopathological studies on cerebrovascular disease. Kyushi J Med Sci. 1964; 15:127.

    CAS  Google Scholar 

  104. Marquardsen J. The natural history of acute cerebrovascular disease: a retrospective study of 769 patients. Acta Neurol Scand. 1969;45(suppl 38): 11.

    PubMed  Google Scholar 

  105. Paffenbarger RS Jr, Laughlin ME, Gima AS, et al. Work activity of longshoremen as related to death from coronary heart disease and stroke. N Engl J Med. 1970;282:1109–1114.

    Article  PubMed  Google Scholar 

  106. Miller FD, Reed DM, MacLean CJ. A prospective study of mortality and morbidity among carpenters in the Honolulu Heart Program Cohort. J Occup Med. 1988;30:879–882.

    Article  PubMed  CAS  Google Scholar 

  107. Kannel WB. Health and obesity: an overview. In: Conn HL Jr, DeFelice EA, Kuo P, eds. Health and Obesity. New York, NY: Raven Press; 1983: p 1.

    Google Scholar 

  108. Welin L, Svardsudd K, Wilhelmsen L, et al. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987;317:521–526.

    Article  PubMed  CAS  Google Scholar 

  109. Bengtsson C, Lapidus L, Stendahl C, et al. Hyperuricaemia and risk of cardiovascular disease and overall death: a 12-year follow-up of population study of women in Gothenburg, Sweden. Acta Med Scan. 1988;224:549–555.

    Article  CAS  Google Scholar 

  110. Syrjanen J, Valtonen VV, Iivanainen M, et al. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J Clin Res. 1988; 196:1156–1160.

    Article  Google Scholar 

  111. Syrjanen J, Peltola J, Valtonen V, et al. Dental infections in association with cerebral infarction in young and middle-aged men. J Intern Med. 1989; 225:179–184.

    Article  PubMed  CAS  Google Scholar 

  112. Boers GH, Smals AG, Trijbels FJ, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med. 1985;313:709–715.

    Article  PubMed  CAS  Google Scholar 

  113. Mudd SH. Vascular disease and homocysteine metabolism. Editorial. N Engl J Med. 1985;313: 751–753.

    Article  PubMed  CAS  Google Scholar 

  114. Brattstrom LE, Israelsson B, Jeppsson JO, et al. Folic acid —an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest. 1988;48: 215–221.

    Article  PubMed  CAS  Google Scholar 

  115. Robins M, Baum HM. The National Survey of Stroke. Incidence. Stroke. 1981 ;12(suppl): 145–155.

    Google Scholar 

  116. Monthly Vital Statistics Report-Final Data From the National Center for Health Statistics. U.S. Department of Health and Human Services, vol. 35, no. 6. September 26, 1986.

    Google Scholar 

  117. London WT, Rosenberg SE, Draper JF, et al. The effect of estrogens on atherosclerosis: a postmortem study. Ann Int Med. 1961;55:63.

    Article  PubMed  CAS  Google Scholar 

  118. Marmorston J. Effect of estrogen treatment in cerebrovascular disease. In: Cerebral Vascular Diseases. New York, NY: Grune & Stratton, 1965: p214.

    Google Scholar 

  119. Rivin AU, Dimitroff SP. The incidence and severity of atherosclerosis in estrogen-treated males, and in females with hypoestrogenic or a hyperes-trogenic state. Circulation. 1954;9:533–539.

    Article  PubMed  CAS  Google Scholar 

  120. Stamler J, Pick R, Katz LN, et al. Effectiveness of estrogens for therapy of myocardial infarction in middle-aged men. JAMA. 1963;183:632–638.

    Article  PubMed  CAS  Google Scholar 

  121. Veterans Administration Cooperative Study Group. Estrogenic therapy in men with ischemic cerebrovascular disease: effect on recurrent cerebral infarction and survival. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section. Stroke. 1972; 3:427–433.

    Article  Google Scholar 

  122. Heyden S, Heyman A, Camplong L. Mortality patterns among parents of patients with atherosclerotic cerebrovascular disease. J Chronic Dis. 1969; 22:105–110.

    Article  PubMed  CAS  Google Scholar 

  123. Khaw KT, Barrett-Connor E. Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol. 1986;123:59–66.

    PubMed  CAS  Google Scholar 

  124. Diaz JF, Hachinski VC, Federson LL, et al. Aggregation of multiple risk factors for stroke in siblings of patients with brain infarction and transient ischemic attacks. Stroke. 1986;17:1239–1242.

    Article  PubMed  CAS  Google Scholar 

  125. Sprafka JM, Folsom AR, Burke GL, et al. Prevalence of cardiovascular disease risk factors in blacks and whites: the Minnesota Heart Survey. Am J Public Health. 1988;78:1546–1549.

    Article  PubMed  CAS  Google Scholar 

  126. Friday G, Lai SM, Alter M, et al. Stroke in the Lehigh valley: racial/ethnic differences. Neurology. 1989;39:1165–1168.

    Article  PubMed  CAS  Google Scholar 

  127. Gillum RF. Stroke in blacks. Stroke. 1988;19:1–9.

    Article  PubMed  CAS  Google Scholar 

  128. Folsum AR, Gomez-Marin O, Sprafka JM, et al. Trends in cardiovascular risk factors in an urban black population, 1973–74 to 1985: the Minnesota heart survey. Am Heart J. 1987; 114:1199–1205.

    Article  Google Scholar 

  129. Katsuki S, Hirota Y, Akazome T, et al. Epidemiological studies on cerebrovascular diseases in Hisayama, Kyushu Island, Japan: Part I. With particular reference to cardiovascular status. Jpn Heart J. 1964;5:12–36.

    Article  Google Scholar 

  130. Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke. 1982; 13:62–73.

    Article  PubMed  CAS  Google Scholar 

  131. Ueda K, Omae T, Hirota Y, et al. Decreasing trend in incidence and mortality from stroke in Hisayama residents, Japan. Stroke. 1981;12:154–60.

    Article  PubMed  CAS  Google Scholar 

  132. Worth RM, Kato H, Rhoads GG, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol. 1975;102:481–490.

    PubMed  CAS  Google Scholar 

  133. Sasaki N. The salt factor in apoplexy and hypertension: epidemiological studies in Japan. In: Yamori Y, Lovinberg W, Freis E, eds. Perspectives in Cardiovascular Research. New York, NY: Raven Press; 1979: pp 467–474.

    Google Scholar 

  134. Takahashi E, Sasaki N, Takeda J, et al. The geographic distribution of cerebral hemorrhage and hypertension in Japan. Human Biol. 1957;29:139–165.

    PubMed  CAS  Google Scholar 

  135. Benfante R, Reed D, Brody J. Biological and social predictors of health in an aging cohort. J Chronic Dis. 1985;38:385–395.

    Article  PubMed  CAS  Google Scholar 

  136. Shimamoto T, Komachi Y, Inada H, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation. 1989;79:503–515.

    Article  PubMed  CAS  Google Scholar 

  137. Tanaka H, Hayashi M, Date C, et al. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke. 1985;16:773–780.

    Article  PubMed  CAS  Google Scholar 

  138. Lin CH, Shimizu Y, Kato H, et al. Cerebrovascular diseases in a fixed population of Hiroshima and Nagasaki, with special reference to relationship between type and risk factors. Stroke. 1984;15:653–660.

    Article  PubMed  CAS  Google Scholar 

  139. Mitsuyama Y, Thompson LR, Hayashi T, et al. Autopsy study of cerebrovascular disease in Japanese men who lived in Hiroshima, Japan and Honolulu, Hawaii. Stroke. 1979;10:389–395.

    Article  PubMed  CAS  Google Scholar 

  140. Resch JA, Okabe N, Loewenson RB, et al. Pattern of vessel involvement in cerebral atherosclerosis: a comparative study between a Japanese and Minnesota population. J Atheroscler Res. 1969;9719.

    Google Scholar 

  141. Takeya Y, Popper JS, Shimizu Y, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke. 1984;15:15–23.

    Article  PubMed  CAS  Google Scholar 

  142. Olivares L, Castaneda E, Grife A, et al. Risk factors in stroke: a clinical study in Mexican patients. Stroke. 1973;4:773–781.

    Article  PubMed  CAS  Google Scholar 

  143. Paffenbarger RS Jr, Wing AL. Chronic disease in former college students. XL early precursors of nonfatal stroke. Am J Epidemiol. 1971;94:524–530.

    PubMed  Google Scholar 

  144. Abbott RD, Donahue RP, MacMahon SW, et al. Diabetes and the risk of stroke: the Honolulu heart program. JAMA. 1987;257:949–952.

    Article  PubMed  CAS  Google Scholar 

  145. Viitanen M, Eriksson S, Asplund K. Risk of recurrent stroke, myocardial infarction and epilepsy. Eur Neurol. 1988;28:227–231.

    Article  PubMed  CAS  Google Scholar 

  146. Kannel WB, Gordon T, Wolf PA, et al. Hemoglobin and the risk of cerebral infarction: the Framingham study. Stroke. 1972;3:409–420.

    Article  PubMed  CAS  Google Scholar 

  147. Pearson TC, Thomas DJ. Physiological and pharmacological factors influencing blood viscosity and cerebral blood flow. In: Tognoni G, Garattini S, eds. Drug Treatment and Prevention in Cerebrovascular Disorders. Amsterdam: Elsevier North Holland; 1979: p 33.

    Google Scholar 

  148. Tohgi J, Yamanouchi H, Murakami M, et al. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke. 1978;9:369–374.

    Article  PubMed  CAS  Google Scholar 

  149. Thomas DJ, Marshall J, Russell RWR, et al. Effect of haematocrit on cerebral blood-flow in man. Lancet. 1977;2:941–943.

    Article  PubMed  CAS  Google Scholar 

  150. Harrison MJG, Pollock S, Kendall BE, et al. Effect of haematocrit on carotid stenosis and cerebral infarction. Lancet. 1981;2:114.

    Article  PubMed  CAS  Google Scholar 

  151. LaRue L, Alter M, Lai SM, et al. Acute stroke, hematocrit, and blood pressure. Stroke. 1987; 18: 565–569.

    Article  PubMed  CAS  Google Scholar 

  152. Ozaita G, Calandre L, Peinado E, et al. Hematocrit and clinical outcome in acute cerebral infarction. Stroke. 1987;18:1166–1168.

    Article  PubMed  CAS  Google Scholar 

  153. Lowe GDO, Jaap JL, Forbes CD. Relation of atrial fibrillation to acute stroke. Lancet. 1983;1:784–786.

    Article  PubMed  CAS  Google Scholar 

  154. Scandinavian Stroke Study Group. Multicentre trial of hemodilution in acute ischemic stroke: I. Results in the total patient population. Stroke. 1987; 18: 691–699.

    Article  Google Scholar 

  155. Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian Haemodilution Trial. Lancet. 1988;1:318–321.

    Google Scholar 

  156. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501–505.

    Article  PubMed  CAS  Google Scholar 

  157. Wolf PA, Kannel WB, Meeks SL, et al. Fibrinogen as a risk factor for stroke, the Framingham study. Stroke. 1985; 16:139.

    Article  Google Scholar 

  158. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA. 1987;258:1183–1186.

    Article  PubMed  CAS  Google Scholar 

  159. Portnoy BA, Herion JC. Neurological manifestations in sickle-cell disease: with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med. 1972;76:643–652.

    Article  PubMed  CAS  Google Scholar 

  160. Kushner M, Simonian N. Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke. 1989;20:225–229.

    Article  PubMed  CAS  Google Scholar 

  161. Levine SR, Welch KM. Cerebrovascular ischemia associated with lupus anticoagulant. Stroke. 1987; 18:257–263.

    Article  PubMed  CAS  Google Scholar 

  162. Young SM, Fisher M, Sigsbee A, et al. Cardiogenic brain embolism and lupus anticoagulant. Ann Neurol. 1989;26:390–392.

    Article  PubMed  CAS  Google Scholar 

  163. Coull BM, Bourdette DN, Goodnight SH, et al. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke. 1987; 18:1107–1112.

    Article  PubMed  CAS  Google Scholar 

  164. Levine SR, Kim S, Deegan MJ, et al. Ischemic stroke associated with anticardiolipin antibodies. Stroke. 1987;18:1101–1106.

    Article  PubMed  CAS  Google Scholar 

  165. Hart RG, Miller VT, Coull BM, et al. Cerebral infarction associated with lupus anticoagulants — preliminary report. Stroke. 1984;15:114–118.

    Article  PubMed  CAS  Google Scholar 

  166. Heyman A, Wilkinson WE, Heyden S, et al. Risk of stroke in asymptomatic persons with cervical arterial bruits: a population study in Evans County, Georgia. N Engl J Med. 1980;302:838–841.

    Article  PubMed  CAS  Google Scholar 

  167. Wolf PA, Kannel WB, Sorlie P, et al. Asymptomatic carotid bruit and risk of stroke. The Framingham study. JAMA. 1981;245:1442–1445.

    Article  PubMed  CAS  Google Scholar 

  168. Conneally PM, Dyken ML, Futty DE, et al. Cooperative study of hospital frequency and character of transient ischemic attacks: VIII. Risk factors. JAMA. 1978;240:742–746.

    Article  PubMed  CAS  Google Scholar 

  169. Dyken ML. Should the efficacy of carotid endar-terectomy in symptomatic patients be examined in a controlled clinical trial? A study is needed. In: Raichle ME, Powers WJ, eds. Cerebrovascular Diseases. New York, NY: Raven Press; 1987.

    Google Scholar 

  170. Dyken ML. Carotid endarterectomy studies: a glimmering of science. Stroke. 1986;17:355–358.

    Article  PubMed  CAS  Google Scholar 

  171. Meissner I, Wiebers DO, Whisnant JP, et al. The natural history of asymptomatic carotid artery occlusive lesions. Ann Neurol. 1986;20:122.

    Google Scholar 

  172. Powers WM, Press GW, Grubb RL Jr, et al. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med. 1987; 106: 27–35.

    Article  PubMed  CAS  Google Scholar 

  173. Powers WJ, Tempel LW, Grubb RL. Influence of cerebral hemodynamics on stroke risk: one-year follow-up of 30 medically treated patients. Ann Neurol. 1989;25:325–330.

    Article  PubMed  CAS  Google Scholar 

  174. Powers WJ, Grubb RL Jr, Raichle ME. Clinical results of extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular disease. J Neurosurg. 1989;70:61–67.

    Article  PubMed  CAS  Google Scholar 

  175. Bogousslavsky J, Regli F, VanMelle G, et al. Migraine stroke. Neurology. 1988;38:223–227.

    Article  PubMed  CAS  Google Scholar 

  176. Bogousslavsky J, Regli F. Ischemic stroke in adults younger than 30 years of age: cause and prognosis. Arch Neurol. 1987;44:479–482.

    Article  PubMed  CAS  Google Scholar 

  177. Rothrock JF, Walicke P, Swenson MR, et al. Migrainous stroke. Arch Neurol. 1988;45:63–67.

    Article  PubMed  CAS  Google Scholar 

  178. Hilton-Jones D, Warlow CP. The causes of stroke in the young. J Neurol. 1985;232:137–143.

    Article  PubMed  CAS  Google Scholar 

  179. Chen TC, Leviton A, Edelstein S, et al. Migraine and other diseases in women of reproductive age: The influence of smoking on observed associations. Arch Neurol. 1987;44:1024–1028.

    Article  PubMed  CAS  Google Scholar 

  180. Pfaffenrath V, Pollmann W, Autenrieth G, et al. Mitral valve prolapse and platelet aggregation in patients with hemiplegic and nonhemiplegic migraine. Acta Neurol Scand. 1987;75:253–257.

    Article  PubMed  CAS  Google Scholar 

  181. Hogan MJ, Brunet DG, Ford PM, et al. Lupus anticoagulant, antiphospholipid antibodies and migraine. Can J Neurol Sci. 1988;15:420–425.

    PubMed  CAS  Google Scholar 

  182. Henrich JB. The association between migraine and cerebral vascular events: an analytical review. J Chronic Dis. 1987;40:329–335.

    Article  PubMed  CAS  Google Scholar 

  183. Kuller L, Anderson H, Peterson D, et al. Nationwide cerebrovascular disease morbidity study. Stroke. 1970;1:86–99.

    Article  PubMed  CAS  Google Scholar 

  184. Nefzger MD, Acheson RM, Heyman A. Mortality from stroke among U.S. veterans in Georgia and five western states: I. Study plan and death rates. J Chronic Dis. 1973;26:393–404.

    Article  PubMed  CAS  Google Scholar 

  185. The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35–64 years. World Health Stat Q. 1988;41:115–140.

    Google Scholar 

  186. Bull GM. Meteorological correlates with myocardial and cerebral infarction and respiratory disease. Br J Prev Soc Med. 1973;27:108–113.

    PubMed  CAS  Google Scholar 

  187. Haberman S, Capildeo R, Rose FC. The seasonal variation in mortality from cerebrovascular disease. J Neuro Sci. 1981;52:25.

    Article  CAS  Google Scholar 

  188. Knox EG. Meteorological associations of cerebrovascular disease mortality in England and Wales. J Epidemiol Community Health. 1981;35: 220–223.

    Article  PubMed  CAS  Google Scholar 

  189. Rogot E, Padgett SJ. Associations of coronary and stroke mortality with temperature and snowfall in selected areas of the United States, 1962–1966. Am J Epidemiol. 1976;103:565–575.

    PubMed  CAS  Google Scholar 

  190. Berginer VM, Goldsmith J, Vardi H, et al. Clustering of strokes in association with meteorologic factors in the Negev desert of Israel. 1981–1983. Stroke. 1989;20:65–9.

    Article  PubMed  CAS  Google Scholar 

  191. Biller J, Jones MP, Bruno A, et al. Seasonal variation of stroke —does it exist? Neuro epidemiology. 1988;7:89–98.

    CAS  Google Scholar 

  192. Marler JR, Price TR, Clark GL, et al. Morning increase in onset of ischemic stroke. Stroke. 1989; 20:473–476.

    Article  PubMed  CAS  Google Scholar 

  193. Acheson RM, Fairbairn AS. Record linkage in studies of cerebrovascular disease in Oxford, England. Stroke. 1971;2:48–57.

    Article  PubMed  CAS  Google Scholar 

  194. Acheson RM, Heyman A, Nefzger MD. Mortality from stroke among U.S. veterans in Georgia and five western states: III. Hypertension and demographic characteristics. J Chronic Dis. 1973 ;26: 417–429.

    Article  Google Scholar 

  195. Mann AH, Brennan PJ. Type A behavior score and the incidence of cardiovascular disease: a failure to replicate the claimed associations. J Psychosom Res. 1987;31:685–692.

    Article  PubMed  CAS  Google Scholar 

  196. Ragland DR, Brand RJ. Type A behavior and mortality from coronary heart disease. N Engl J Med. 1988;318:65–69.

    Article  PubMed  CAS  Google Scholar 

  197. Eaker ED, Castelli WP. Type A behavior and mortality from coronary disease in the Framingham study. N Engl J Med. 1988;319:1480–1481.

    Article  PubMed  CAS  Google Scholar 

  198. Kannel WB, Wolf PA. Epidemiology of cerebrovascular disease. In: Ross Russell RW, ed. Vascular Disease of the Central Nervous System. 2nd ed. London: Churchill Livingston; 1983.

    Google Scholar 

  199. Longstreth WT Jr, Swanson PD. Oral contraceptives and stroke. Stroke. 1984;15:747–750.

    Article  PubMed  Google Scholar 

  200. Sobel E, Alter M, Davanipour Z, et al. Stroke in the Lehigh valley: combined risk factors for recurrent ischemic stroke. Neurology. 1989;39:669–672.

    Article  PubMed  CAS  Google Scholar 

  201. Miettinen TA, Huttunen JK, Naukkarinen V, et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men: risk factor changes, incidence, and mortality. JAMA. 1985; 254:2097–2102.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Mark L. Dyken
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, M4N 3M5, Canada

    John W. Norris M.D.

  2. Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, N6A 5A5, Canada

    Vladimir C. Hachinski M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dyken, M.L. (1991). Stroke Risk Factors. In: Norris, J.W., Hachinski, V.C. (eds) Prevention of Stroke. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4226-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4226-8_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-4228-2

  • Online ISBN: 978-1-4757-4226-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation